Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1974 1
1975 1
1982 2
1983 3
1984 3
1985 7
1986 6
1987 1
1988 4
1989 2
1990 4
1991 2
1992 2
1993 3
1994 4
1995 5
1996 12
1997 2
1998 5
1999 4
2000 2
2001 5
2002 5
2003 8
2004 8
2005 9
2006 6
2007 5
2008 10
2009 8
2010 10
2011 7
2012 13
2013 8
2014 5
2015 11
2016 12
2017 15
2018 12
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

219 results
Results by year
Filters applied: . Clear all
Page 1
Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.
Perez-Vilar S, Weibel D, Sturkenboom M, Black S, Maure C, Castro JL, Bravo-Alcántara P, Dodd CN, Romio SA, de Ridder M, Nakato S, Molina-León HF, Elango V, Zuber PLF; WHO Global Vaccine Safety-Multi Country Collaboration. Perez-Vilar S, et al. Vaccine. 2018 Jan 8;36(3):347-354. doi: 10.1016/j.vaccine.2017.05.012. Epub 2017 May 27. Vaccine. 2018. PMID: 28558983 Free PMC article. Clinical Trial.
Incidence rate ratios (IRR) of 5.0 (95% CI: 2.5-9.7) for ITP following first dose of measles-containing vaccinations, and of 10.9 (95% CI: 4.2-27.8) for AM following mumps-containing vaccinations were found. ...A significantly elevated AM risk for vaccines co …
Incidence rate ratios (IRR) of 5.0 (95% CI: 2.5-9.7) for ITP following first dose of measles-containing vaccinations, and of 10.9 (95 …
Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells.
Zhang AH, Yoon J, Kim YC, Scott DW. Zhang AH, et al. J Immunol. 2018 Sep 1;201(5):1434-1441. doi: 10.4049/jimmunol.1701800. Epub 2018 Jul 18. J Immunol. 2018. PMID: 30021767 Free PMC article.
In hemophilia, for example, up to one third of patients receiving therapeutic factor VIII (FVIII) infusions develop neutralizing Abs termed "inhibitors." ...Such BAR-Tregs specifically suppressed the recall Ab response of spleen cultures from FVIII-immunized mice in …
In hemophilia, for example, up to one third of patients receiving therapeutic factor VIII (FVIII) infusions develop neutralizing Abs …
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.
Schechter ME, Andrade BB, He T, Richter GH, Tosh KW, Policicchio BB, Singh A, Raehtz KD, Sheikh V, Ma D, Brocca-Cofano E, Apetrei C, Tracy R, Ribeiro RM, Sher A, Francischetti IMB, Pandrea I, Sereti I. Schechter ME, et al. Sci Transl Med. 2017 Aug 30;9(405):eaam5441. doi: 10.1126/scitranslmed.aam5441. Sci Transl Med. 2017. PMID: 28855397 Free PMC article.
Factors Associated With Refusal of Intramuscular Vitamin K in Normal Newborns.
Loyal J, Taylor JA, Phillipi CA, Goyal NK, Wood KE, Seashore C, King B, Colson E, Shabanova V, Shapiro ED; BORN investigators. Loyal J, et al. Pediatrics. 2018 Aug;142(2):e20173743. doi: 10.1542/peds.2017-3743. Pediatrics. 2018. PMID: 30030367 Free PMC article.
Our objective was to assess the frequency of and factors associated with refusal of IM vitamin K administration in well newborns in the United States. ...Refusal of the administration of both ocular prophylaxis and hepatitis B vaccine was also strongly associ …
Our objective was to assess the frequency of and factors associated with refusal of IM vitamin K administration in well newborns in the U
Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D, Khuri N, Dong GQ, Winter MB, Shifrut E, Friedman N, Craik CS, Pratt KP, Paz P, Aswad F, Sali A. Schneidman-Duhovny D, et al. PLoS One. 2018 Nov 6;13(11):e0206654. doi: 10.1371/journal.pone.0206654. eCollection 2018. PLoS One. 2018. PMID: 30399156 Free PMC article.
Accurate predictions of T-cell epitopes would be useful for designing vaccines, immunotherapies for cancer and autoimmune diseases, and improved protein therapies. ...To validate the method using a clinically relevant application, we utilized five factor VIII-specific TCR …
Accurate predictions of T-cell epitopes would be useful for designing vaccines, immunotherapies for cancer and autoimmune diseases, a …
Reasons for Refusal of Newborn Vitamin K Prophylaxis: Implications for Management and Education.
Hamrick HJ, Gable EK, Freeman EH, Dunn LL, Zimmerman SP, Rusin MM, Linthavong OR, Wright ME, Moss LA, Skinner AC. Hamrick HJ, et al. Hosp Pediatr. 2016 Jan;6(1):15-21. doi: 10.1542/hpeds.2015-0095. Hosp Pediatr. 2016. PMID: 26711469 Free article.
Most refused hepatitis B vaccine (90%) and erythromycin eye ointment (77%). The most common source of information was the Internet (70%). ...
Most refused hepatitis B vaccine (90%) and erythromycin eye ointment (77%). The most common source of information was the Internet (7 …
A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.
Merlin S, Cannizzo ES, Borroni E, Bruscaggin V, Schinco P, Tulalamba W, Chuah MK, Arruda VR, VandenDriessche T, Prat M, Valente G, Follenzi A. Merlin S, et al. Mol Ther. 2017 Aug 2;25(8):1815-1830. doi: 10.1016/j.ymthe.2017.04.029. Epub 2017 May 26. Mol Ther. 2017. PMID: 28552407 Free PMC article.
Hemophilia A (HA) is an X-linked bleeding disease caused by factor VIII (FVIII) deficiency. We previously demonstrated that FVIII is produced specifically in liver sinusoid endothelial cells (LSECs) and to some degree in myeloid cells, and thus, in the present work, we see
Hemophilia A (HA) is an X-linked bleeding disease caused by factor VIII (FVIII) deficiency. We previously demonstrated that FVIII is
Effects of Thermomechanical Stimulation during Vaccination on Anxiety, Pain, and Satisfaction in Pediatric Patients: A Randomized Controlled Trial.
Redfern RE, Chen JT, Sibrel S. Redfern RE, et al. J Pediatr Nurs. 2018 Jan-Feb;38:1-7. doi: 10.1016/j.pedn.2017.09.009. Epub 2017 Sep 28. J Pediatr Nurs. 2018. PMID: 29167074 Clinical Trial.
PURPOSE: Vaccination can be a significant source of pain for pediatric patients, which could result in fear of medical procedures and future reluctance to seek medical care. ...PRACTICE IMPLICATIONS: The Buzzy device is an easy to implement intervention to reduce pediatric …
PURPOSE: Vaccination can be a significant source of pain for pediatric patients, which could result in fear of medical procedures and …
A 19-year old man with IgA vasculitis after vaccination.
Malek A, Gomez-Villegas SI, de la Hoz A, Nowbakht C, Arias CA. Malek A, et al. Braz J Infect Dis. 2018 Sep-Oct;22(5):442-444. doi: 10.1016/j.bjid.2018.09.004. Epub 2018 Oct 30. Braz J Infect Dis. 2018. PMID: 30389353 Free article.
A 19-year-old patient who mistakenly received two doses of influenza vaccine 10 days before presentation, was admitted with malaise, weakness, and a purpuric non-blanching rash most prominent on the ankles followed by abdominal pain and hematochezia 72h later. The diagnosi …
A 19-year-old patient who mistakenly received two doses of influenza vaccine 10 days before presentation, was admitted with malaise, …
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F, Cicalese MP, Galimberti S, Giannelli S, Dionisio F, Barzaghi F, Migliavacca M, Bernardo ME, Calbi V, Assanelli AA, Facchini M, Fossati C, Albertazzi E, Scaramuzza S, Brigida I, Scala S, Basso-Ricci L, Pajno R, Casiraghi M, Canarutto D, Salerio FA, Albert MH, Bartoli A, Wolf HM, Fiori R, Silvani P, Gattillo S, Villa A, Biasco L, Dott C, Culme-Seymour EJ, van Rossem K, Atkinson G, Valsecchi MG, Roncarolo MG, Ciceri F, Naldini L, Aiuti A. Ferrua F, et al. Lancet Haematol. 2019 May;6(5):e239-e253. doi: 10.1016/S2352-3026(19)30021-3. Epub 2019 Apr 10. Lancet Haematol. 2019. PMID: 30981783 Free PMC article. Clinical Trial.
The primary efficacy endpoints were overall survival, sustained engraftment of genetically corrected HSPCs, expression of vector-derived WASP, improved T-cell function, antigen-specific responses to vaccinations, and improved platelet count and mean platelet volume normali …
The primary efficacy endpoints were overall survival, sustained engraftment of genetically corrected HSPCs, expression of vector-derived WAS …
219 results
Jump to page
Feedback